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Background. Docosahexaenoic acid (DHA, 22:6n-3) and arachidonic acid (ARA, 20:4n-6) are the major long chain
polyunsaturated fatty acids (LCPUFA) of the central nervous system (CNS). These nutrients are present in most infant
formulas at modest levels, intended to support visual and neural development. There are no investigations in primates of the
biological consequences of dietary DHA at levels above those present in formulas but within normal breastmilk levels.
Methods and Findings. Twelve baboons were divided into three formula groups: Control, with no DHA-ARA; ‘‘L’’, LCPUFA,
with 0.33%DHA-0.67%ARA; ‘‘L3’’, LCPUFA, with 1.00%DHA-0.67%ARA. All the samples are from the precentral gyrus of cerebral
cortex brain regions. At 12 weeks of age, changes in gene expression were detected in 1,108 of 54,000 probe sets (2.05%), with
most showing ,2-fold change. Gene ontology analysis assigns them to diverse biological functions, notably lipid metabolism
and transport, G-protein and signal transduction, development, visual perception, cytoskeleton, peptidases, stress response,
transcription regulation, and 400 transcripts having no defined function. PLA2G6, a phospholipase recently associated with
infantile neuroaxonal dystrophy, was downregulated in both LCPUFA groups. ELOVL5, a PUFA elongase, was the only LCPUFA
biosynthetic enzyme that was differentially expressed. Mitochondrial fatty acid carrier, CPT2, was among several genes
associated with mitochondrial fatty acid oxidation to be downregulated by high DHA, while the mitochondrial proton carrier,
UCP2, was upregulated. TIMM8A, also known as deafness/dystonia peptide 1, was among several differentially expressed
neural development genes. LUM and TIMP3, associated with corneal structure and age-related macular degeneration,
respectively, were among visual perception genes influenced by LCPUFA. TIA1, a silencer of COX2 gene translation, is
upregulated by high DHA. Ingenuity pathway analysis identified a highly significant nervous system network, with epidermal
growth factor receptor (EGFR) as the outstanding interaction partner. Conclusions. These data indicate that LCPUFA
concentrations within the normal range of human breastmilk induce global changes in gene expression across a wide array of
processes, in addition to changes in visual and neural function normally associated with formula LCPUFA.
Citation: Kothapalli KSD, Anthony JC, Pan BS, Hsieh AT, Nathanielsz PW, et al (2007) Differential Cerebral Cortex Transcriptomes of Baboon Neonates
Consuming Moderate and High Docosahexaenoic Acid Formulas. PLoS ONE 2(4): e370. doi:10.1371/journal.pone.0000370
INTRODUCTION
The vertebrate central nervous system (CNS) is rich in the long
chain polyunsaturated fatty acids (LCPUFA) docosahexaenoic
acid (DHA) and arachidonic acid (ARA), and this composition is
highly conserved across species[1]. Within the CNS, DHA and
ARA are found at highest concentration in gray matter[2], and
DHA is particularly concentrated in retinal photoreceptor mem-
branes where it has long been known to play a key role in visual
excitation[3]. In humans, DHA and ARA accumulate perinatal-
ly[4] and many studies of DHA/ARA supplemented formula show
improvements in visual acuity[5] and cognitive function[6].
Despite the high demand for LCPUFA during perinatal CNS
development, the best current evidence indicates that ARA and
DHA can be synthesized only very inefficiently from dietary
precursors and must be obtained from the diet[7]. DHA and ARA
are present in all human milks studied to date[8], however their
concentration is variable. For DHA it is closely linked to the
mother’s intake of preformed DHA, which is in turn reflective of
the mother’s intake of fatty fish or fish/marine oil supple-
ments[9,10,11,12]. Dietary factors associated with ARA are less
well understood[13]. High levels of precursor fatty acids LA and
ALA in formulas yield negligible or at most moderate increases
in plasma ARA and DHA concentrations[14,15]. However, in
randomized controlled studies where preterm and term infants are
fed preformed DHA and ARA supplemented formula, improve-
ments in LCPUFA status as well as cognitive development and
visual functions are observed [16,17,18,19,20].
While the importance of LCPUFA in infant nutrition has been
established, the underlying mechanisms are only beginning to be
understood. Brain accretion of LCPUFA is most intense during
the brain growth spurt in the third trimester of pregnancy and
during early childhood[21,22,23,24]. Selective incorporation and
functional properties of LCPUFA, especially DHA, in retinal and
neural membranes suggests a specific role in the modulation of
protein-lipid interactions, membrane bound receptor function,
membrane permeability, cell signaling, regulation of gene
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ly, LCPUFA mediate metacrine regulation and changes in gene
expression by interacting with nutrient sensitive transcription
factors [18,31]. Accordingly, poor nutrition during prenatal life
and early infancy may have a lasting influence on neural function,
as well as adult risk for chronic diseases [32,33,34]. Studies suggest
that infant diets low in LCPUFA can lead to health complications
such as insulin resistance, obesity, or blood pressure changes later
in life [35,36].
DHA and ARA were introduced in 2002 to infant formulas in
the United States, but initial concentrations varied over more than
a factor of two (range of DHA 8-19 mg/kcal; ARA 21-34 mg/
kcal),[37] and there are no dose response studies in humans or
non-human primates available as a guide to optimal levels. A
previous study in our laboratory on 4-week-old baboon neonates
with preformed DHA and ARA (0.33%,w/w DHA and 0.67%
ARA) in formulas showed DHA concentrations in various regions
of the brain similar to breastfed controls, with the important
exception of the cerebral cortex; ARA concentrations were not
much altered by inclusion of dietary preformed ARA[2]. These
results inspired our present study on 12 week old baboon neonates
with the higher level of 1.00% DHA, along with 0.67% ARA. We
report elsewhere [38] that DHA in the precentral gyrus of cerebral
cortex increased beyond that achieved for 0.33% DHA, while
regions such as the basal ganglia that reached DHA concentra-
tions similar to breastfed animals at 0.33% DHA did not show
further increases with 1.00% DHA. These data demonstrate that
formula DHA in the high normal range of breastmilk DHA
supports enhanced cortex DHA, but do not reveal how this
compositional change may influence metabolic function.
To gather mechanistic information on the role of DHA and
ARA in the primate cerebral cortex, we investigated global gene
expression for cerebral cortex of animals in this study, consuming
two different levels of formula DHA both within the range found
in human breastmilk[8]. We report here changes in expression of
thousands of genes in 12-week-old baboons in response to two
different levels of LCPUFA: 0.33%DHA and 0.67% ARA; 1.00%
DHA and 0.67% ARA. We have reported in detail on
consequences for tissue fatty acid composition [38] and other
factors elsewhere (Hsieh et al., 2007, submitted).
RESULTS AND DISCUSSION
Significance analysis (P,0.05) identified changes in expression
levels of 1108 probe sets (ps) for comparisons of L3/C and/or L/
C, representing 2.05% of the total.54,000 ps on the oligoarray.
Most ps showed ,2-fold change. For the L/C comparisons,
534 ps were upregulated, and 574 ps were downregulated, while
for the L3/C comparisons, 666 ps were upregulated and 442 ps
were downregulated, showing that more genes were upregulated
in the cerebral cortex in response to increasing formula ARA and
DHA. Functional characterization by gene ontology of these
differentially regulated genes assigns them to diverse biological
processes including lipid and other metabolism, ion channel and
transport, development, visual perception, G-protein and signal
transduction, regulation of transcription, cell cycle, cell pro-
liferation, apoptosis etc. Known functions were assigned to 702
differentially expressed probe sets, whereas 406 ps had no known
functions as shown in Table S1A, S1B, S1C, S1D. Probe sets with
$1.4 fold expression change are presented in Table S2.
Experimental details for nine genes used for confirmatory RT-
PCR analysis are presented in Table S3. We note that in our L/C
and L3/C comparisons, expression patterns fall into four groups,
L/C and L3/C both upregulated and both downregulated, or one
upregulated and one downregulated. Because the L and L3 groups
have the same amount of ARA but different amounts of DHA, our
treatments do not strictly represent a DHA dose response. The
L/C comparison corresponds to inclusion of DHA and ARA at
current levels near the worldwide breastmilk means, while the L3
group corresponds to DHA near the worldwide high [8].
Nine genes were tested by quantitative real time PCR to
confirm the array results, as shown in Table S4. All were
qualitatively consistent with the gene array results.
We highlight results in several categories of gene ontogeny as
follows.
Lipid (fatty acid and cholesterol) Metabolism
Table 1 presents results from genes related to lipid metabolism
that are regulated by dietary LCPUFA.
Genes related to phospholipids biosynthesis (PLA2G6 and
DGKE) were differentially expressed. PLA2G6 was downregulated
in both groups. This gene codes for the Ca-independent cytosolic
phospholipase A2 Group VI. Alterations in this gene have very
recently been implicated as a common feature of neurodegener-
Table 1. Lipid and energy metabolism gene fold-changes in
expression profiles.
......................................................................
Metabolism Gene Symbol Unigene ID L L3
Lipid ATP8B1 Hs.569910 1.28 1.36
PDE3A Hs.386791 1.08 1.30
ELOVL5 Hs.520189 21.02 1.11
ACSL3 Hs.471461 21.13 1.08
HNF4A Hs.116462 1.06 21.16
CLPS Hs.1340 1.02 21.16
ALDH3B2 Hs.87539 1.05 21.16
PLCE1 Hs.20022 21.10 21.19
Fatty acid oxidation ACADSB Hs.81934 21.10 1.38
ACAD10 Hs.331141 21.08 1.10
GLYAT Hs.274336 1.01 1.30
ADH5 Hs. 78989 1.03 1.22
CPT2 Hs.145384 1.10 21.22
Energy LEP Hs.194236 21.01 1.17
Ceramide NSMAF Hs.372000 21.04 1.31
LASS5 Hs.270525 1.06 1.11
Glycosphingolipid SPTLC2 Hs.435661 1.27 1.40
Steroid OSBP2 Hs.517546 21.17 1.35
UGT2B15 Hs.150207 1.04 1.21
SULT2B1 Hs.369331 1.04 21.38
Phospholipid DGKE Hs.546318 21.10 1.17
PLA2G6 Hs.170479 21.09 21.20
Prostaglandin and
Leukotriene
TEBP Hs.50425 1.02 1.52
ANXA3 Hs.480042 1.26 21.04
LTC4S Hs.456 21.33 21.24
Cholesterol DHCR24 Hs.498727 21.18 1.17
PRKAG2 Hs.131133 21.07 1.09
PRKAA1 Hs.43322 1.09 21.02
SOAT1 Hs.496383 21.09 21.12
FDFT1 Hs.546253 1.01 21.13
doi:10.1371/journal.pone.0000370.t001
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LCPUFA and Brain Transcriptome
PLoS ONE | www.plosone.org 2 April 2007 | Issue 4 | e370ative disorders involving iron accumulation [39], as well as the
underlying factor in infantile neuroaxonal dystrophy, a neurode-
generative disorder caused by accumulation of iron in the globus
pallidus and resulting in death by age 10[40]. In a previous study of
four week old breastfed baboons, the globus pallidus was found to
have 15.860.5% DHA (w/w of total fatty acids) and was the richest
in DHA of 26 CNS regions examined[2]. The globus pallidus is also
rich in ARA, with 10.3% (w/w) in four week old baboons. PLA2 are
a superfamily of enzymes that liberate fatty acids from the sn-2
position of phospholipids; in the globus pallidus DHA and ARA are
the most abundant acyl groups at this site.
Remarkably, among the elongation and desaturation enzymes
associated with LCPUFA synthesis, only a single elongation en-
zyme was differentially expressed. The human ELOVL5 transcript
was downregulated slightly in the L/C group and upregulated in
the L3/C group. This enzyme, also called HELO1, catalyzes the
two carbon elongation of polyunsaturated 18 and 20 carbon fatty
acids [41,42].
We also found that DGKE was upregulated in the L3/C compar-
ison. Genes involved in ceramide metabolism (NSMAF, LASS5),
glycosphingolipid metabolism (SPTLC2) and steroid metabolism
(OSBP2, UGT2B15) showed increased expression in L3/C group,
whereas NSMAF and OSBP2 were downregulated in L/C group.
The best studied role of ARA is as a precursor for eicosanoids
including prostaglandins, leukotrienes, and thromboxanes. One of
the genes derived from membrane-bound ARA, which catalyze
the first step in the biosynthesis of cysteinyl leukotrienes, Leuko-
triene C4 synthase (LTC4S), is downregulated in both DHA-ARA
groups. LTC4S is a potent proinflammatory and anaphylactic
mediator [43]. An elevated level of mRNAfor PGES3 (prostaglandin
E synthase 3) was observed in both the groups. PGES3 is also known
as TEBP (telomerase-binding protein p23) or inactive progesterone
receptor, 23-KD (p23). p23, a ubiquitous highly conserved protein
which functions as a co-chaperone for the heat shock protein,
HSP90, participates in the folding of a number of cell regulatory
proteins [44,45]. p23 has been demonstrated to bind to human
telomerase reverse transcriptase (hTERT) and contribute to
telomerase activity [46]. Decreased levels of Annexin A3 (ANXA3)
also known as Lipocortin III was observed with increasing DHA.
Genes involved in fatty acid oxidation (ACADSB, ACAD10 and
GLYAT) were upregulated, and carnitine palmitoyltransferase II
(CPT2) downregulated, in the L3/C group. ACADs (acyl-CoA
dehydrogenases) are a family of mitochondrial matrix flavopro-
teins that catalyze the dehydrogenation of acyl-CoA derivatives
and are involved in the b-oxidation and branched chain amino-
acid metabolism [47,48]. Both the ACADs family members
ACADSB and ACAD10 were upregulated in L3/C group, con-
sistent with greater energy production in the high DHA group.
Mitochondrial-specific GLYAT (glycine-N-acyltransferase) also
known as acyl CoA:glycine N-acyl transferase (ACGNAT), con-
jugates glycine with acyl-CoA and participates in detoxification of
various drugs and xenobiotics [49,50]. Mawal et al [50] suggested
that delayed development of GLYAT might impair detoxification
process in children.
Genes involved in cholesterol biosynthesis, DHCR24, PRKAG2,
PRKAA1, SOAT1,a n dFDFT1 showed significant associations with
LCPUFA levels. Increasing DHA upregulated DHCR24 and
PRKAG2, downregulated PRKAA1, SOAT1 and FDFT1. DHCR24
(24-dehydrocholesterol reductase) also known as selective AD
indicator1(SELADIN1)catalyzesthereductionofthedelta-24double
bond of sterol intermediates during cholesterol biosynthesis [51].
SELADIN1 may activate estrogen receptor in the brain and protect
from beta-amyloid-mediated toxicity [52]. Decreased expression of
SELADIN1 is observed in brain regions of patients with Alzheimer’s
disease [53]. PRKAG2 (protein kinase, AMP-activated, gamma 2) is
a memberofAMP-activated proteinkinase (AMPK)family.AMPKs
perform multifunctional roles in calcium signaling, weight loss,
regulation of energy metabolism in heart [54,55,56].
SOAT1 (sterol O-acyl transferase) or Acyl-coenzyme A: choles-
terol acyl transferase (ACAT) is an intracellular protein which
catalyzes the formation of cholesterol esters in endoplasmic
reticulum and is involved in lipid droplets that are characteristic
of foam cells of atherosclerotic plaques [57,58,59].
Increased expression was detected for ATP8B1, PDE3A in both
groups, comparatively more in L3/C, while transcripts involving
HNF4A (Hepatic nuclear factor-4a), CLPS and ALDH3B2 showed
decreased expression with increasing DHA. Intrahepatic chole-
stasis, or impairment of bile flow, is an important manifestation of
inherited and acquired liver disease resulting in hepatic accumu-
lation of the toxic bile acids and progressive liver damage. Bile
acids enhance efficient digestion and absorption of dietary fats and
fat-soluble vitamins, and are the main route for excretion of
sterols. Expression of ATP8B1 is high in the small intestine, and
mutations in ATP8B1 gene have been linked to intrahepatic
cholestasis [60,61]. ATP8B1 expression was confirmed by real time
PCR (Table S4). PDE3A (phosphodiesterase 3A, cGMP-inhibited)
is a 120 kDa protein found in myocardium and platelets [62].
Ding et al[63] showed significantly decreased expression of PDE3A
in the left ventricles of failing human hearts. PDE3A expression is
required for the regulation of penile erection in humans [64].
Leptin (LEP), which has a role in energy metabolism, was
upregulated in L3/C group. Leptin is a secreted adipocyte hor-
mone that plays a pivotal role in the regulation of food intake and
energy homeostasis [65,66]. Leptin suppresses feeding and
decreases adiposity in part by inhibiting hypothalamic Neuropep-
tide Y synthesis and secretion [67,68].
Ion Channel and Transport
Expression levels of transcripts involved in ion channel and
transporter activity were altered by dietary LCPUFA (Table S5).
Uncoupling protein 2, LOC131873 (hypothetical protein) and
ATP11C, which have ion channel activity, are upregulated in both
the groups but moreso in L3/C. Other transcripts with ion
channel activity, including VDAC3, FTH1, KCNK3, KCNH7 and
TRPM1 were upregulated in L3/C group and downregulated in
L/C. GLRA2, TRPV2 and HFE are upregulated in L/C and
repressed in L3/C. P2RX2, GRIA1 and CACNA1S are repressed in
both the groups.
One of our significant observations is the increased expression
of uncoupling protein 2 (UCP2), a mitochondrial, proton carrier.
Our data shows, for the first time, increased expression of UCP2 in
neonatal cerebral cortex associated with dietary LCPUFA;
increased expression is observed in both the groups but more in
L3/C. QRT-PCR confirmed the array results (Table S4).
Nutritional regulation and induction of mitochondrial uncoupling
proteins resulting from dietary n3-PUFA in skeletal muscle and
white adipose tissue have been observed [69,70]. Increased UCP2
expression is beneficial in diseases associated with neurodegenera-
tion, cardiovascular and type 2 diabetes[71]. Dietary fats in milk
increased the expression and function of UCP2 in neonatal brain
and protected neurons from excitotoxicity [72].
VDAC3 (voltage-dependent anion channel 3) belongs to a group
of pore forming proteins found in the outer mitochondrial
membrane and in brain synaptic membranes [73,74]. Massa et al
[75] observed a significant reduction of VDAC3 mRNA levels in
the skeletal muscle and brains of dystrophin-deficient mdx mice
during postnatal development. Mice lacking VDAC3 exhibit
infertility [76]. All the transcripts (VDAC3, KCNK3 and KCNH7)
LCPUFA and Brain Transcriptome
PLoS ONE | www.plosone.org 3 April 2007 | Issue 4 | e370having voltage-gated anion channel porin activity were upregu-
lated with increasing DHA. FTH1 (Ferritin heavy chain 1) is
required for iron homeostasis and it has been previously shown to
be expressed in human brain [77].
Genes encoding small molecule transporters were differentially
expressed, including carriers of glucose (SLC2A1, SLC5A4),
chloride (SLC12A6), sodium (SLC13A3), monoamine (SLC18A2)
and others (SLC26A4, SLC17A6). These transporters might help in
exchange of nutrients and metabolites. Members of the cyto-
chrome P and B family of proteins were also differentially
expressed. Transcripts encoding VDP, RSAFD1, C1QG and OXA1L
were significantly repressed by increasing DHA.
G-Proteins and Signaling
Numerous genes encoding G-protein activity were differentially
regulated (Table S5), and the majority were induced by high
DHA. GNA13, GNA14, PTHR2, RCP9 and FZD3 showed increased
expression in both DHA groups. EDG7, SH3TC2, GNRHR,
ADRA1A, BLR1, GPR101, GPR20 and OR8G2 were downregulated
in L/C and upregulated in L3/C. NPY1R is downregulated in
both the groups.
DHA regulates G-protein signaling in the brain and retina [78].
G-proteins are membrane-associated proteins which promote
exchange of GTP for GDP and regulate signal transduction and
membrane traffic[79]. GNA13 deficiency impairs angiogenesis in
mice [80] while GNA14 activates the NF-kB signaling cascade
[81]. Parathyroid hormone receptor 2 (PTHR2) is activated by
parathyroid hormone and is relatively abundant in the CNS
[82,83]. RCP9, also known as calcitonin gene-related peptide-
receptor component protein, may have a role during hematopoi-
esis [84]. Tissir and Goffinet [85] showed expression of FZD3
during postnatal CNS development in mice. FZD3 array results
were confirmed by SYBR green real time PCR assay (Table S4).
Neuropeptide Y is a 36-amino acid peptide with strong orexi-
genic effects in vivo [86]. Two major subtypes of NPY (Y1 and Y2)
have been defined by pharmacologic criteria. NPY1R was sug-
gested to be unique for the control of feeding [87]. Pedrazzini et al
[88] observed a moderate but significant decrease in food intake in
mice lacking the NPY1R gene.
EDG7 (endothelial differentiation, lysophosphatidic acid G-
protein-coupled receptor, 7) mediates calcium mobilization[89].
Mutation in the SH3TC2 gene causes childhood-onset of a neuro-
degenerative disorder affecting motor and sensory neurons[90].
Several signaling proteins (NF1, WSB1, SOCS4, RIT1, CD8B1,
OR2A9P and RERG) were upregulated in both groups. Genes that
are upregulated in L3/C and downregulated in L/C were also
observed, specifically PDE4D, KRAS, ITGA2, PLCXD3, WNT8A,
ARHGAP4, RAPGEF6, OR2F1/OR2F2, CCM1 and SFRP2, while
a few genes (WNT10A, ADCY2, OGT, DDAH1 and BCL9) were
upregulated in L/C and downregulated in L3/C. IQGAP3, GCGR,
APLN, CYTL1, GRP, LPHN3, CNR1, VAV3 and MCF2 were
downregulated in both the groups (Table S5).
NF1 is a tumor-suppressor gene; mutations in this gene cause
neurocutaneous defects [91]. NF1 gene expression and function
are needed for normal fracture healing [92]. NF1 expression levels
were confirmed by QRT-PCR (Table S4). WSB1 is a SOCS-box-
containing WD-40 protein expressed during embryonic develop-
ment in chicken [93]. RAS and RAS related gene families of small
GTPases (RIT1, KRAS, RERG and RAPGEF6) were upregulated by
increasing DHA.
Diets deficient in n-3 PUFA induce substitution of n-6 DPA
(22:5n-6) in neural membranes, and impairment of functions
mediated by G protein mediated signaling, such as visual percep-
tion, learning and memory, and olfactory discrimination. Abun-
dant evidence indicates that this results in reduced rhodopsin
activation, and signaling in rod outer segments compared to DHA-
replete animals[78,94,95,96,97].
Development
Table 2 shows differential expression of 24 genes related to
development. The products of 11 transcripts play a role in nervous
system development. The expression of TIMM8A, NRG1, SEMA3D
and NUMB genes were upregulated in both L/C and L3/C
groups. HES1 and SIM1 were downregulated in both the groups.
GDF11, SMA3/SMA5, SH3GL3 were downregulated in L/C and
upregulated in L3/C. The mRNA levels of growth factors FGF5
and FGF14 displayed increased abundance in L/C and decreased
abundance in L3/C.
TIMM8A also known as Deafness/Dystonia Peptide 1 (DDP1)i s
a well conserved protein organized in mitochondrial intermem-
brane space. Loss-of-Function mutations in the TIMM8A gene
cause Mohr-Tranebjaerg syndrome (a progressive neurodegener-
ative disorder with deafness, blindness, dystonia and mental defici-
ency) and Jensen syndrome (opticoacoustic nerve atrophy with
dementia) [98,99,100]. TaqMan assay confirmed the array results
(Table S4). NRG1 is essential for the development and function of
the CNS facilitating the neuronal migration and axon guidance
[101,102]. NUMB negatively regulates notch signaling and plays
a role in retinal neurogenesis, influencing the proliferation and
differentiation of retinal progenitors and maturation of postmitotic
Table 2. Development gene fold-changes in expression
profiles.
......................................................................
Development Gene Symbol Unigene ID L L3
Nervous system TIMM8A Hs.447877 1.04 1.57
NRG1 Hs.453951 1.02 1.21
SEMA3D Hs.201340 1.10 1.14
NUMB Hs.585653 1.01 1.10
HES1 Hs.250666 21.30 21.63
SIM1 Hs.520293 21.16 21.16
GDF11 Hs.591023 21.18 1.09
SMA3///SMA5 Hs.482414/484969/
588240
21.08 1.06
SH3GL3 Hs.270055/458285 21.16 1.04
FGF5 Hs.37055 1.08 21.20
FGF14 Hs.591206 1.01 21.10
Muscle C6orf97 Hs.130239 21.03 1.34
CALD1 Hs.490203 1.09 1.14
Skeletal BAPX1 Hs.105941 1.05 1.08
Heart GATA4 Hs.243987 21.02 1.22
Epidermis S100A7 Hs.112408 21.06 1.27
FGF7 Hs.122006 1.14 1.02
SCEL Hs.115166 21.01 21.13
Ectoderm/
Mesoderm
SMURF1 Hs.189329 1.15 1.32
TCF21 Hs.78061 21.12 21.18
Gametogenesis OTEX Hs.196956 1.09 1.24
TCP11 Hs.435371 21.02 1.08
CDV1 Hs.528382 21.001 21.10
SPAG6 Hs.527698 21.03 21.22
doi:10.1371/journal.pone.0000370.t002
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PLoS ONE | www.plosone.org 4 April 2007 | Issue 4 | e370neurons [103]. HES1 (Hairy/Enhancer of Split, Drosophila,
Homolog of, 1) a basic helix-loop-helix protein is downregulated.
Decreased expression of HES1 is observed as neurogenesis pro-
ceeds and in case of persistent expression differentiation of
neuronal cells are blocked in the CNS [104].
Visual Perception
Nine transcripts having a role in visual perception were differ-
entially expressed (Table 3). Genes coding for LUM, EML2, TIMP3
and TTC8 were upregulated in both the supplement groups.
IMPG1 was upregulated in L3/C and downregulated in L/C.
RGS16 and TULP2 were upregulated in L/C and downregulated
in L3/C. RAX and IMPDH1 were downregulated in both the
supplement groups.
Lumican (LUM), is an extracellular matrix glycoprotein and
a member of the small-leucine-rich-proteoglycan (SLRP) family
[105]. It is widely distributed in the corneal stoma and connective
tissues [106]. Lumican helps in the establishment of corneal
stromal matrix organization during neonatal development in mice.
Those lacking lumican exhibit several corneal related defects
[107]. It is important for corneal transparency in mice [108].
TaqMan assay showed 5-fold more upregulation of LUM more
than the microarray data (Table S4). Mutations in TIMP3 gene
result in autosomal dominant disorder Sorsby’s fundus dystrophy
an age-related macular degeneration of retina [109]. Clarke et al
[110] suggested that a possible mechanism for retinal degeneration
in Sorsby’s fundus dystrophy was traceable to nutrition.
IMPG1 is a proteoglycan which participates in retinal adhesion
and photoreceptor survival [111]. Higher amounts of DHA in the
infant formula increased the expression of IMPG1. Expression of
RAX transcript is decreased in both the supplement groups.
Increased RAX expression is seen in the retinal progenitor cells
during the vertebrate eye development and is downregulated in
the differentiated neurons[112,113]. DHA is well known to pro-
mote neurite growth in the brain [30]; this could be the possible
reason for RAX downregulation in our study.
Integral to Membrane/Membrane Fraction
Transcripts that are integral part of biological membranes or
within the membrane fractions were differentially expressed (Table
S5). EVER1, PERP, Cep192, SSFA2, LPAL2, TMEM20, TM6SF1
were upregulated in both the groups. ORMDL3, SEZ6L, HYDIN,
TA-LRRP, PKD1L1 were upregulated in L3/C and downregulated
in L/C. MFAP3L was upregulated in L/C and downregulated in
L3/C. Transcripts of GP2 and SYNGR2 were downregulated in
both the groups.
Numbers of transcripts were upregulated by increased DHA in
the formulas. LCPUFA can affect biological membrane functions
by influencing membrane composition and permeability, interaction
with membrane proteins, membrane-bound receptor function,
photoreceptor signal transduction and transport [114,115,116].
Mutations inEVER1 or transmembrane channel-like 6 (TMC6) gene
cause epidermodysplasia verruciformis, a type of skin disorder [117].
HYDINisanovel gene and nearly-completelossofitsfunction dueto
mutations causes congenital hydrocephalus in mice [118]. The exact
function of GP2 is unknown, but it has been associated with the
secretory granules in the pancreas [119].
Programmed Cell Death/Apoptosis
Transcripts with apoptotic activity were differentially expressed
(Table S5). Seven out of nine transcripts in our study were
upregulated with increasing DHA, including CARD6, TIA1,
BNIP1, FAF1, GULP1, CASP9 and FLJ13491. Programmed cell
death (PCD) plays an important role during the development of
immune and nervous systems [120]. Jacobson et al [121] proposed
PCD as an important event in eliminating unwanted cells during
development. Mice with targeted deletion of CASP3 die perinatally
due to vast excesses of cells deposition in their CNS as a result of
decreased apoptotic activity [120]. CARD6 (caspase recruitment
domain protein 6) is upregulated in both the groups. It is
a microtubule-interacting protein that activates NF- B and takes
part in the signaling events leading to apoptosis [122]. TIA1 is
upregulated in L3/C and downregulated in L/C. TIA1 is
a member of RNA-binding protein family with pro-apoptotic
activity, and it silences the translation of cyclooxygenase-2 (COX2).
Narayanan et al, [123] suggested that DHA indirectly increases
the expression of genes which downregulate COX2 expression.
The COX2 enzyme catalyzes the rate-limiting step for prostaglan-
din production, which influence many processes including in-
flammation [124]. Downregulation of TIA1 in L/C could be due
to the influence of ARA, the major COX2 substrate, rather than
that of DHA which is a competitive inhibitor. GULP1 assists in
efficient removal of the apoptotic cells by phagocytosis [125].
CASP9 activates caspase activation cascade and is an important
component of mitochondrial apoptotic pathway [126].
Cytoskeleton and Cell adhesion
Dietary LCPUFA regulated expression of several transcripts
involved in cytoskeleton and cell adhesion (Table S5). The
expression of 27 ps involved in cytoskeleton was altered. MYO1A
and MYO5A were upregulated with increasing amounts of DHA
whereas MYO1E showed decreased expression. Myosin-1 isoforms
are membrane associated molecular motors which play essential
roles in membrane dynamics, cytoskeletal structure and signal
transduction [127]. COL4A6 and COL9A3 showed increased
expression whereas COL4A2 and COL9A2 showed decreased
expression with increasing DHA. Type IV collagen is the major
component of the basement membrane. Mild forms of Alport
nephropathy is associated with deletion in COL4A6 gene [128] and
eye abnormalities are common in people afflicted with Alport
syndrome [129]. WASL, also known as neural WASP (WASP), was
upregulated in both the groups. Actin cytoskeleton regulation is
vital for brain development and function. WASL is an actin-
Table 3. Visual perception gene fold-changes in expression
profiles.
......................................................................
Gene Product Unigene ID L L3
Lumican (LUM) Hs.406475 1.03 1.30
Interphotoreceptor matrix proteoglycan 1
(IMPG1)
Hs.590893 21.03 1.18
Echinoderm microtubule associated protein
like 2 (EML2)
Hs.24178 1.07 1.15
TIMP metallopeptidase inhibitor 3 (TIMP3) Hs.297324 1.28 1.05
Tetratricopeptide repeat domain 8 (TTC8) Hs.303055 1.10 1.01
IMP (inosine monophosphate)
dehydrogenase 1 (IMPDH1)
Hs.534808 21.20 21.12
Tubby like protein 2 (TULP2) Hs.104636 1.07 21.15
Retina and anterior neural fold homeobox
(RAX)
Hs.278957 21.10 21.24
Regulator of G-protein signalling 16
(RGS16)
Hs.413297 1.01 21.26
doi:10.1371/journal.pone.0000370.t003
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
LCPUFA and Brain Transcriptome
PLoS ONE | www.plosone.org 5 April 2007 | Issue 4 | e370regulating protein and mediates filopodium formation
[130,131,132]. HIP1 (huntingtin interacting protein 1) and
HOOK2 (hook homolog 2) were downregulated in both the groups.
The expression levels of 15 transcripts involved in cell adhesion
changed as a result of dietary LCPUFA (Table S5). BTBD9, CD44,
ARMC4, CD58, LOC389722 and PCDHB13 showed increased
expression in both the groups. Glycoprotein CD44 is a cell-surface
adhesion molecule that is involved in cell-cell and cell-matrix
interactions [133] while PCDHB13 is a member of protocadherin
beta family of transmembrane glycoproteins [134]. NLGN3 and
CYR61 were downregulated in both groups.
Peptidases
Several transcripts having peptidase activity were differentially
expressed (Table S5). SERPINB6 is significantly upregulated in
L3/C and downregulated in L/C. Of note, the ADAM families of
proteins (ADAM17, ADAM33, and ADAMTS16) were upregulated
and ADAMTS15 was downregulated in both the supplement
groups. ADAM proteins are membrane-anchored glycoproteins
named for two of the motifs they carry: an adhesive domain
(disintegrin) and a degradative domain (metalloprotease) [135].
These proteins are involved in several biological processes
including cell-cell interactions, heart development, neurogenesis
and muscle development [136,137,138,139]. ADAM17 is required
for proteolytic processing of other proteins and have been reported
to participate in cleaving of the amyloid precursor protein
[140,141]. Loss of ADAM17 is reported in abnormalities associated
with heart, skin, lung and intestines [142,143,144]. Real time PCR
confirmed array results of ADAM17 (Table S4). ADAM33 has been
recently implicated as an asthma and bronchial hyperresponsive-
ness gene [145]. It is required for smooth muscle development in
the lungs helps in airway wall ‘‘modeling’’, and proper functioning
of lungs throughout life [146,147].
CTSB (Cathepsin B) also known as amyloid precursor protein
secretase (APPS) was upregulated. It is involved in the proteolytic
processing of amyloid precursor protein [148]. Felbor et al [149]
reported deficiency of CTSB results in brain atrophy and loss of
nerve cells in mice. CTSC (Cathepsin C) was downregulated in the
L/C group and upregulated in the L3/C group. Loss of function
mutations in CTSC gene are associated with tooth and skin
abnormalities [150].
NAALAD2 was upregulated while PAPLN, RNF130, TMPRSS2,
PGC, CPZ, FURIN were downregulated. CPZ interacts with WNT
proteins and may regulate embryonic development, however, its
expression in adult tissues is less abundant [151]. TPP2 and
SPPL2B showed increased expression in L/C and decreased
expression in L3/C. PAPPA, GZMA, SERPINA1, QPCTL tran-
scripts were downregulated in L/C and upregulated in L3/C.
Several hypothetical proteins (FLJ10504, FLJ30679, FLJ90661,
FLJ25179, DKFZp686L1818) were differentially expressed.
Cell Cycle, Cell Growth and Cell Proliferation
Fifteen transcripts having a role in cell cycle regulation, growth
and proliferation were differentially expressed (Table S5). Four of
the transcripts SESN3, RAD1, GAS1 and PARD6B involved in cell
cycle regulation were upregulated in both the groups. Cell growth
factors, INHBC and OGN were induced in both the groups.
FGFR1OP is a positive regulator of cell proliferation and showed
increased expression. KAZALD1, CDC20 and CDKN2C were
downregulated.
Growth arrest specific gene 1 (GAS1) expression is positively
required for postnatal cerebellum development. Mice lacking
GAS1 had significantly reduced cerebellar size compared to wild
type mice [152]. Liu et al [152] proposed that GAS1 perform dual
roles in cell cycle arrest and in proliferation in a cell autonomous
manner. PARD6B has a role in axonogenesis [153].
INHBC is a member of transforming growth factor-beta super-
family (TGF-beta) and is involved cell growth and differentiation
[154,155]. Osteoglycin (OGN) is also known as Mimecan and
Osteoinductive factor (OIF). Mimecan is a member of small-
leucine rich proteoglycan gene family and is a major component of
cornea and other connective tissues [156,157]. It has a role in
bone formation , cornea development and regulation of collagen
fibrillogenesis in corneal stroma [157,158,159]. CDC20 regulates
anaphase-promoting complex [160].
Response to Stress
MSRA, SOD2, GSTA3 and GSR genes were differentially expressed
(Table S5). MSRA was upregulated in both the supplement groups.
SOD2 is downregulated in L/C and upregulated in L3/C. GSR is
upregulated in the L/C and downregulated in the L3/C. GSTA3 is
downregulated in both the groups.
Oxidative damage to proteins by reactive oxygen species is
associated with oxidative stress, aging, and age-related diseases
[161,162,163]. MSRA is expressed in the retina, neurons and the
nervous system [162]. Knock-outs of the MSRA gene in mice result
in shortened life-spans both under normoxia and hyperoxia con-
ditions [164]. MSRA also participates in the regulation of proteins
[165]. MSRA plays an important role in neurodegenerative
diseases like Alzheimer’s and Parkinson’s by reducing the effects
of reactive oxygen species [163]. Overexpression of MSRA protects
human fibroblasts against H2O2-mediated oxidative stress [166].
SOD2 belongs to the iron/manganese superoxide dismutase family.
It encodes a mitochondrial protein and helps in the elimination of
reactive oxygen species generated within mitochondria [167]. In
our study increased amount of DHA reduced the expression of
glutathione-related proteins GSR and GSTA3.
Kinases and Phosphatases
Phosphorylation and dephosphorylation of proteins control
a multitude of cellular processes. Several proteins having kinase
activity were altered (Table S5). Of note, transcripts involving
STK3, STK6, HINT3, TLK1, DRF1, GUCY2C and NEK1 were
significantly upregulated with increasing DHA. A number of MAP
kinases were downregulated in L3/C group, including MAP4K1,
MAPK12, MAP3K2 and MAP3K3. Other transcripts which showed
significantly decreased expression were CKM, LMTK2, NEK11,
TNK1, BRD4 and MGC4796.
Transcripts havingdephosphorylation activity, including ACPL2,
KIAA1240, PPP2R3A, PPP1R12B, PTPRG, PPP3CA and ACPP
were upregulated in L3/C group (Table S5). MTMR2, PPP1R7,
PTPRN2 and HDHD3 were significantly downregulated with
increasing DHA.
Transcription Factors
Several transcription factors are differentially expressed by dietary
LCPUFA (Table S5). Zinc finger proteins, Homeo box proteins
and RNA Pol II transcription factors were among them. Several of
the Zinc finger proteins were upregulated in L3/C, which include
ZNF611, ZNF584, ZNF81, ZNF273, ZNF547, MYNN, ZBTB11,
PRDM7, JJAZ1, ZNF582, MLLT10, ZNF567, ZNF44, ZNF286,
ZFX, NAB1, ZNF198, ZNF347 and ZNF207, while PCGF2, ZBTB9,
ZNF297, WHSCIL1, SALL4, ZNF589, ZFY, ZNF146, ZNF419 and
ZNF479 were repressed in L3/C group. Zinc finger proteins
exhibit varied biological functions in eukaryotes including activa-
tion of transcription, protein folding, regulation of apoptosis, lipid
LCPUFA and Brain Transcriptome
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PHTF1, OTP and HHEX were induced whereas PHOX2A, IRX1
and MITF were repressed in L3/C. RNA Pol II transcription
factors (BRCA1, TFCP2, CHD2, THRAP3, SMARCD2 and NFE2L2)
showed increased expression in L3/C. However, transcripts for
UTF1, POU2F2, ELL, POLR2C, THRAP5, TGIF and GLIS1
showed decreased expression in L3/C. SOX7 and SOX12, high
mobility group (HMG) box proteins, were also differentially
expressed. ZNF611 array expression results were confirmed by real
time PCR (Table S4).
Receptor Activity
Transcripts performing receptor activities were differentially
expressed (Table S5). While increasing levels of DHA were
associated with decreased expression of CD40, ITGB7, IL20RA,
CD14, DOK3, MR1, BZRAP1, RARA, CD3D, IL1R1, MCP,
HOMER3 transcripts, increased expression was detected for
FCGR2B, IL31RA, MRC2, SCUBE3, CR2, NCR2, CRLF2, SLAMF1,
EGFR and KIR3DL2. Interestingly, retinoic acid receptor a (RARA)
activity was decreased in both the groups. EGFR expression levels
were confirmed by QRT-PCR (Table S4).
Ubiquitin Cycle
Twenty-five probe sets having a role in the ubiquitination process
were differentially expressed (Table S5). Interestingly, five
members of F-box protein family (FBXL7, FBXL4, FBXL17,
FBXW4 and FBXW8) showed increased expression in L3/C
group. F-Box proteins participate in varied cellular processes such
as signal transduction, development, regulation of transcription
and transition of cell cycle. They contain protein-protein
interaction domains and participate in phosphorylation-dependent
ubiquitination [169,170]. Proteins associated with anaphase-
promoting complex (CDC23 and ANAPC1) were downregulated
in L3/C group.
Others
Transcripts involved in 1) calcium ion binding (MGC33630,
UMODL1, FLJ25818, S100Z, MGC12458, ITSN2 and PRRG3), 2)
zinc ion binding (FGD5, ZFYVE28, PDLIM4, ZCCHC6, ZNF518
and INSM2), 3) ATP binding (MMAA and C6orf102), 4) GTP
binding (DOCK5, DOCK6, DOCK10, MFN1 and GTP), 5) nucleic
acid binding (IFIH1, C13orf10, DDX58, TNRC6C, RSN, ZCCHC5,
DJ467N11.1, MGC24039 and LOC124245), 6) DNA binding
(KIAA1305, HP1-BP74, H2AFY, C17orf31, HIST1H2BD and
HIST1H1E) 7) protein binding (ABTB1, MGC50721, RANBP9,
STXBP4, BTBD5 and KLHL14) and 8) protein folding (HSPB3,
DNAJB12, FKBP11 and TBCC) were all differentially expressed.
Also, several transcripts which play a role in RNA processing
events were differentially expressed. SFRS2IP, LOC81691,
EXOSC2, SFPQ, SNRPN and SFRS5 showed increased expression,
whereas, NOL5A, RBM19, NCBP2 and PHF5A showed decreased
expression with increasing DHA. Transcripts related to immune
response are also differentially expressed. HLA-DPB1, MX2 and
IGHG1 were upregulated and PLUNC was downregulated with
increasing DHA.
Finally, 406 transcripts with no known gene ontology functions
were differentially expressed (Table S5). Several of these
transcripts were among the most differentially expressed, among
these, H63, LOC283403, FLJ13611, PARP6, C6orf111, C10orf67,
TTTY8, C11orf1 and PHAX were upregulated, whereas transcripts
for CHRDL2, TSGA13, RP4-622L5, MGC5391, RNF126P1,
FAM19A2 and NOB1P were repressed considerably.
Ingenuity Network Analysis
We explored relationships among sets of genes using Ingenuity
Systems network analysis. Out of 1108 differentially expressed
probe sets in our data, 387 probe sets (34.93%) were found in the
Ingenuity Pathway Analysis (IPA) knowledge database, and are
labeled ‘‘focus’’ genes. Based on these focus genes, IPA generated
41 biological networks (Table S6). Among these 41 networks, 24
had scores of .8 and the top 2 networks with 35 genes had scores
of 49. We focus here on the most significant network.
The top network identified by IPA is associated with nervous
system development and function, cellular growth and pro-
liferation (Figure 1). Epidermal growth factor receptor (EGFR)i s
the most outstanding interaction partner found within the
network. EGFR interacts with TIMP3, NRG1, ADAM17, EDG7
and FGF7; all are upregulated, and involved in neural or visual
perception development. EGFR signaling is implicated in early
events of epidermal, neural and eye development. Loss of EGFR
signaling results in reduced brain size and loss of larval eye and
optic lobe in drosophila [171]. EGFR expression is required for
postnatal forebrain and astrocytes development in mice [172].
Functional pathway analysis conducted on this network using the
IPA tool set identified three genes, ADAM17, NUMB and HES1,
involved in the Notch signaling pathway which regulates nervous
system and eye development [173,174]. ADAM17 and NUMB
were upregulated while HES1 was repressed in both the groups.
This analysis suggests that LCPUFA influence many processes
with influences that converge on EGFR.
LCPUFA are known to directly interact with nutrient sensitive
transcription factors such as peroxisome proliferator-activated
receptors (PPARs), liver6receptors, hepatic nuclear factor-4a,
sterol regulatory binding proteins, retinoid6receptors and NF- B.
Upon ingestion, LCPUFA can elicit a transcriptional response
within minutes[31,175,176,177]. Microarray studies on LCPUFA-
supplementing animals have identified several tissue-specific
pathways regulated by LCPUFA, particularly involving the liver,
adipose, and brain tissue transcriptome [26,178,179]. Using
murine 11K Affymetrix oligoarrays, Berger et al [178] [180]
showed increased hepatic expression of lipolytic and decreased
expression of lipogenic genes. However, in the hippocampus brain
region, increased expression of HTR4 and decreased expression of
TTR and SIAT8E, genes involved in the regulation of cognition
and learning, as well as POMC, a gene associated with appetite
control, was identified. The first paper published on the brain gene
transcriptome with respect to LCPUFA supplementation by
Kitajka et al. in 2002 [181] demonstrated that feeding fish oil
(DHA 26.9%) to rats increased expression of genes involved in
lipid metabolism (SPTLC2, FPS), energy metabolism (ATP
synthase subunit d, ATP synthase H
+, cytochromes, IDH3G),
cytoskeleton (Actin related protein 2, TUBA1), signal transduction
(Calmodulins, SH3P4, RAB6B small GTPase), receptors, ion
channels and neurotransmission (Vasopressin V1b receptor,
Somatostatin), synaptic plasticity (Synucleins) and regulatory
proteins (protein phosphatases). In the same study, fish oil
supplementation also significantly reduced the expression of
phospholipase D and Transthyretin. In related work, Kitajka et
al [26] , using rat cDNA microarrays with 3,200 spots, found
results similar to those previously reported. Barcelo-Coblijn et al.
[182] were the first to report moderation of age-induced changes
in gene expression in rat brain as a result of diets rich in fish oil
(DHA 11.2%). In this study, 2 month old rats showed increased
expression of SNCA and TTR, however, 2-year old rats exhibited
no significant changes. In addition, Puskas et al. [183] demon-
strated that administration of omega-3 fatty acids from fish oil (5%
EPA and 27% DHA; total fat content: 8%) for 4 weeks in 2 year
LCPUFA and Brain Transcriptome
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creatine kinase and decreased expression of HSP86, ApoC-I and
Makorin RING zinc-finger protein 2, genes in hippocampus brain
region. Finally, Flachs et al [179] showed increased expression of
genes for mitochondrial proteins in adipose tissue.
In comparison with previous brain transcriptome analyses, the
present study employing the use of high-density Affymetrix
oligoarrays (.54,000 ps) revealed genes differentially regulated
by LCPUFA at ranges mimicking breastmilk. With the exception
of SPTLC2, which we also found to be upregulated in the L/C and
L3/C comparisons, none of the remaining, previously identified
genes, were differentially expressed in our dataset. Many factors
are likely to contribute to the observed differences in differentially
expressed genes between our study and previous work. One likely
source is the difference in dietary DHA/ARA, which is within the
range of human and baboon breastmilk; previous studies used
much higher amounts of DHA, from 11.2% to 27% [182,183].
Also, interactions between levels of ARA and DHA supplied in our
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Figure 1. Ingenuity network analysis showing gene interactions generated from L3/C comparisons. Network is graphically represented as nodes
(genes) and edges (the biological relationship between genes).
doi:10.1371/journal.pone.0000370.g001
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treatments do not represent a strict dose response to DHA.
However, our DHA and ARA come from sources that are
routinely consumed by human infants in commercial infant
formulas, and thus are directly relevant to that group. Despite
lower levels of DHA/ARA, genes in our data set show subtle
changes in expression. Moreover, the magnitude of these results is
not surprising given the nutritional focus of the study, in which
subtle, widespread shifts in transcription may have profound
biological effects. Our data indicate that LCPUFA supplementa-
tion within the ranges of breastmilk will induce global changes in
gene expression across numerous biological processes.
Conclusions
The impact of DHA and ARA on infant baboons was both signi-
ficant and widespread. We identified several novel differentially-
expressed transcripts in 12-week old baboon cerebral cortexes
modulated by dietary LCPUFA. The majority of probe sets
showed subtle changes in gene transcription. In the cerebral
cortex, we observed increased expression of mitochondrial proton
carrier, UCP2 (uncoupling protein 2) in both groups, but more in
L3/C. PLA2G6, implicated in childhood neurodegeneration, was
differentially expressed. TIA1, a silencer of the COX2 gene transla-
tion is upregulated in L3/C. Increased expression was observed
for TIMM8A, NRG1, SEMA3D and NUMB, genes involved in
neural development. LUM, EML2, TIMP3 and TTC8 genes with
roles in visual perception were upregulated. Hepatic nuclear
factor-4a (HNF4A) showed decreased expression with increasing
DHA. RARA was repressed in both the groups. A network
involving 35 genes attributed to neural development and function
was identified using Ingenuity pathway analysis, emphasizing
EGFR as the most outstanding interaction partner in the network.
In this network EGFR interacts with genes involved in neural or
visual perception, TIMP3, NRG1, ADAM17, EDG7 and FGF7.
Although subtle, the upregulation of NUMB and downregulation
of HES1 in the Notch signaling pathway, not previously shown to
interact with fatty acids, supports the involvement of LCPUFA,
particularly DHA, in neural development. Interestingly, no known
desaturases and only one elongase, LCPUFA biosynthetic
enzymes, were differentially expressed in cerebral cortex. In a
study of liver gene expression in preparation, fatty acid desaturases
SCD and FADS1 were significantly downregulated in liver, where
we identified a multifunctional protein TOB1 which is significantly
upregulated.
These data represent the first comprehensive transcriptome
analysis in primates and have identified widespread changes in
cerebral cortex genes that are modulated by increases in DHA,
induced by dietary means. Importantly, the range of DHA used
here is within limits of human and primate breastmilks, the natural
food for infants, and indicate that CNS gene expression responds
to LCPUFA concentrations.
MATERIALS AND METHODS
Details of experimental design, animal characteristics, and tissue
sampling are available elsewhere [38] and will be outlined briefly
here.
Animals and Diets
The animal phase took place at the Southwest Foundation for
Biomedical Research (SFBR), San Antonio, TX, and was
approved for animal care and research protocols from SFBR
and Cornell University Institutional Animal Care and Use
Committee (IACUC). Twelve baboon neonates born spontane-
ously around 182 days gestation were randomized into 3 groups
(n=4 per group). They were fed for 12 weeks on one of
three formulas: C: Control (no DHA-ARA); L: 16LCPUFA
(0.33%DHA-0.67%ARA); L3: 36LCPUFA (1.00%DHA-
0.67%ARA). Formulas in color-coded cans were kindly provided
by Mead-Johnson Nutritionals (Evansville, IN) in ready-to-feed
form, 2 colors per treatment, so that investigators were masked to
the treatments.
Sampling and Array Hybridization
Twelve week old baboon neonates were anesthetized and
euthanized at 84.461.1 days. Tissue collected from the precentral
gyrus of the cerebral cortex was placed in RNALater according to
vendor instructions and was used for the microarray analysis and
validation of microarray results.
Microarray studies utilizing baboon samples with human oligo-
nucleotide arrays have been successfully carried out previous-
ly[184,185]. Cerebral cortex global messenger RNA in the three
groups was analyzed using Affymetrix Genechip
TM HG-U133
Plus 2.0 arrays ,http://www.affymetrix.com/products/arrays/
specific/hgu133plus.affx.. The HG-U133 Plus 2.0 has .54,000
probe sets representing 47,000 transcripts and variants, including
38,500 well-characterized human genes. One hybridization was
performed for each animal (12 chips total). RNA preparations and
array hybridizations were processed at Genome Explorations,
Memphis, TN ,http://www.genome-explorations.com.. The
completed raw data sets were downloaded from the Genome
Explorations secure ftp servers.
Microarray Data Analysis
Raw data (.CEL files) were uploaded into Iobion’s Gene Traffic
MULTI 3.2 (Iobion Informatics, La Jolla, CA, USA) and analyzed
by using the robust multi-array analysis (RMA) method. In
general, RMA performs three operations specific to Affymetrix
GeneChip arrays: global background normalization, normaliza-
tion across all of the selected hybridizations, and log2 trans-
formation of perfect match oligonucleotide probe values [186].
Statistical analysis using the significance analysis tool set in Gene
Traffic was utilized to perform Multiclass ANOVA on all probe
level normalized data. Pairwise comparisons were made between
C vs L and C vs L3 and all probe set comparisons reaching P
,0.05 were included in the analysis. Gene lists of differentially
expressed probe sets were generated from this output for
functional analysis.
Bioinformatics analysis
Expression data was annotated using NIH DAVID ,http://
apps1.niaid.nih.gov/david. [187] and NetAffx ,http://www.
affymetrix.com/analysis/index.affx.. Genes were grouped into
functional categories and pathways based on the Gene Ontology
Consortium ,http://www.geneontology.org., Kyoto Encyclo-
pedia of Genes and Genomes (KEGG) pathway Database
,http://www.genome.jp/kegg/pathway.html. and ,BioCarta
,http://www.biocarta.com/.. Data presented in this manuscript
is accessible through GEO Series accession number GSE6519
(GEO, http://www.ncbi.nlm.nih.gov/geo/).
RNA Isolation and RT PCR
RT PCR was conducted on nine genes to confirm the results of the
array analysis. Total RNA from 30 mg samples of baboon cerebral
cortex brain tissue homogenates was extracted using the RNeasy
Mini kit (Qiagen, Valencia, CA). Each RNA preparation was
treated with DNase I according to the manufacturer’s instructions.
LCPUFA and Brain Transcriptome
PLoS ONE | www.plosone.org 9 April 2007 | Issue 4 | e370The yield of total RNA was assessed by 260 nm UV absorption.
The quality of RNA was analyzed by 260/280 nm ratios of the
samples and by agarose gel electrophoresis to verify RNA
integrity.
One microgram total RNA from each group (C, L, L3) was
reverse-transcribed into first strand cDNA using the iScript cDNA
synthesis kit (Bio-Rad, Hercules, CA). The iScript reverse
transcriptase is a modified MMLV-derived reverse transcriptase
and the iScript reaction mix contains both oligo(dT) and random
primers. The generated first strand cDNA is stored at 220uC until
used.
Quantitative real-time PCR using SYBR green and TaqMan
assay methods was used to verify the differential expression of
selected genes that were upregulated in L3/C comparison. All the
primers were gene-specific and generated from human sequences
,www.ensembl.org.. PCR primers were designed with Primer-
Quest software (IDT, Coralville, IA) and ordered from Integrated
DNA Technologies (IDT, Coralville, IA). Initially primers were
tested by polymerase chain reactions with baboon cerebral cortex
brain cDNA as template in a 30 ml reaction volume using
Eppendorf gradient thermal cycler (Eppendorf), with 1 mm of each
primer, 0.25 mM each of dNTPs, 3 mlo f1 0 6PCR buffer (Perkin-
Elmer Life Sciences, Foster City, CA, USA), 1.5 mM MgCl2 and
1.5 U Taq polymerase (Ampli Taq II; Perkin-Elmer Life Sciences).
Thermal cycling conditions were: initial denaturation at 95uC for
5 min followed by 25–35 cycles of denaturation at 95uC for 30 s,
annealing at 60uC for 1 min and extension at 72uC for 1 min, with
a final extension at 72uC for 2 min. PCR products were separated
by electrophoresis on 2% agarose gel stained with ethidium
bromide and bands of appropriate sizes were obtained. The PCR
products of LUM, TIMM8A, UCP2, ß-ACTIN, ADAM17 and
ATP8B1 were sequenced and deposited with GenBank (Acc
Numbers: DQ779570, DQ779571, DQ779572, DQ779573,
DQ779574 and DQ779575,
respectively).
Initially standardized primers for genes (ATP8B1, ADAM17,
NF1, FZD3, ZNF611, UCP2, EGFR and control ß-ACTIN) were
used for SYBR green real time PCR assay (Power SYBR Green
PCR Master Mix, Applied Biosystems, Foster City, CA). We used
the baboon LUM, TIMM8A and ß-ACTIN sequences to design
TaqMan Assay (Assay by Design; ,www.appliedbiosystems.
com.). The selected gene symbols, primer pairs and probe details
are depicted in Table S3. Quantitative real time PCR reactions
were done with the Applied Biosystems Prism 7300/7500 real time
PCR system (Applied Biosystems, Foster City, CA). After
2 minutes of UNG activation at 50uC, initial denaturation at
95uC was carried out for 10 minutes, the cycling conditions of 40
cycles consisted of denaturation at 95uC for 15 seconds, annealing
at 60uC for 30 seconds, and elongation at 72uC for 1 minute. For
SYBR green method UNG activation step is eliminated. All
reactions were done in triplicate and ß-ACTIN was used as the
reference gene. Relative quantification was performed by using
comparative CT method (ABI Relative Quantification Chemistry
guide # 4347824).
Network Analysis
We used a new web-delivered bioinformatics tool set, Ingenuity
pathway analysis (IPA 3.0) ,http://www.ingenuity.com.,t o
identify functional networks influenced by our dietary treatments.
IPA is a knowledge database generated from the peer-reviewed
scientific publications that enables discovery, visualization and
exploration of functional biological networks in gene expression
data and delineates the functions most significant to those
networks. The 1108 differentially expressed probe sets identified
by microarray data, as discussed below, were used for network
analyses. Affymetrix probe set ID’s were uploaded into IPA and
queried against all other genes stored in the IPA knowledge
database to generate a set of networks having up to 35 genes. Each
Affymetrix probe set ID was mapped to its corresponding gene
identifier in the IPA knowledge database. Probe sets representing
genes having direct interactions with genes in the IPA knowledge
database are called ‘‘focus’’ genes, which were then used as
a starting point for generating functional networks. Each
generated network is assigned a score according to the number
of differentially regulated focus genes in our dataset. These scores
are derived from negative logarithm of the P indicative of the
likelihood that focus genes found together in a network due to
random chance. Scores of 4 or higher have 99.9% confidence level
of significance as defined in detail elsewhere [188].
SUPPORTING INFORMATION
Table S1A Genes with known function upregulated by L3
(1.00%DHA-0.67%ARA) in Brain
Found at: doi:10.1371/journal.pone.0000370.s001 (0.16 MB
XLS)
Table S1B Genes with known function downregulated by L3
(1.00%DHA-0.67%ARA) in Brain
Found at: doi:10.1371/journal.pone.0000370.s002 (0.18 MB
XLS)
Table S1C Genes without known function upregulated by L3
(1.00%DHA-0.67%ARA) in Brain
Found at: doi:10.1371/journal.pone.0000370.s003 (0.08 MB
XLS)
Table S1D Genes without known function downregulated by L3
(1.00%DHA-0.67%ARA) in Brain
Found at: doi:10.1371/journal.pone.0000370.s004 (0.07 MB
XLS)
Table S2 Probe sets showing $1.4 fold changes in gene
expression
Found at: doi:10.1371/journal.pone.0000370.s005 (0.02 MB
XLS)
Table S3 Primers and Probe Sequences
Found at: doi:10.1371/journal.pone.0000370.s006 (0.02 MB
XLS)
Table S4 Comparison of microarray versus QRT-PCR gene
expression values (Fold-changes)
Found at: doi:10.1371/journal.pone.0000370.s007 (0.01 MB
XLS)
Table S5 Classification According to Gene Ontology Functions
for Brain
Found at: doi:10.1371/journal.pone.0000370.s008 (0.28 MB
XLS)
Table S6 Ingenuity functional network analysis
Found at: doi:10.1371/journal.pone.0000370.s009 (0.07 MB
XLS)
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